Updated time: 2024-03-14 16:18:21
26A-1090219
2020-10-30
TW I768415
This invention uses microfluidics and nano-SPR (surface plasmon resonance) technology to develop a portable urine detector that can detect microRNA (miR) in the urine of UCC patients and will be extended to clinical use.
The characterizations are following:
- New urinary biomarkers of UCC
- A rapid nanoimprinting method and nano-SPR biosensor
- A portable SPR system for detecting biomarkers in urine sample
In recent years, many new micro-RNA and long strand non coding RNA markers have been discovered for various diseases. The nano-SPR sensing platform to be developed in this invention can be rapidly adapted to detect different diseases. There will be various applications using this platform
- Non-invasive, early detection of UCC, facilitating early stage treatment and reducing relapse and death rate.
- More accessible and acceptable and less invasive than current cystoscopy. Convenient for post-operational monitoring.
- Automated multiple miRNA marker detection, enhanced specificity/sensitivity and reduced detection time and cost than conventional methods.
- In-vitro diagnostic devices and reagents
- Biochip and instrument for diagnosis, chip fabrication automation system

Fig1. Schematic of representation of the automated SPR measurement system.
Ji-Yen Cheng, Pei-Kuen Wei, et al.
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

A portable device for analysis of urinary microRNAs of urothelial carcinoma (UCC)